PrEP Users With AUD Under-Treated, Study Finds
June 2, 2025
-
3 min
A recent study found that nearly 15% of patients initiating human immunodeficiency virus preexposure prophylaxis (PrEP) had an alcohol use disorder (AUD) diagnosis within 6 months, with only a small proportion receiving FDA-approved treatment. The study also highlighted the underdiagnosis of AUD prior to PrEP initiation and undertreatment following initiation, emphasizing the need for improved screening and access to evidence-based treatments for AUD in this population.
1. 15% of patients initiating PrEP had an alcohol use disorder diagnosis within 6 months. 2. Only 8.46% of patients with AUD received an FDA-approved medication. 3. The underdiagnosis of AUD prior to PrEP initiation and undertreatment following initiation was highlighted. 4. The study emphasized integrating mental health assessments into regular care alongside PrEP services. 5. Improved screening and access to evidence-based treatments for AUD in this population is necessary to support PrEP adherence and HIV prevention efforts.
Listen Tab content
